kabutan

SAWAI GROUP HOLDINGS Co.,Ltd.(4887) Summary

4887
TSE Prime
SAWAI GROUP HOLDINGS Co.,Ltd.
2,250.5
JPY
+2.0
(+0.09%)
Dec 12, 3:30 pm JST
14.44
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
2,250.5
Dec 12, 10:54 pm JST
Summary Chart Historical News Financial Result
PER
18.5
PBR
1.47
Yield
2.44%
Margin Trading Ratio
1.39
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
2,268.0 JPY 14.58 USD
Previous Close Dec 11
2,248.5 JPY 14.40 USD
High Dec 12, 9:01 am
2,273.0 JPY 14.62 USD
Low Dec 12, 9:17 am
2,233.0 JPY 14.35 USD
Volume
482,400
Trading Value
1.09B JPY 6.98M USD
VWAP
2252.89 JPY 14.46 USD
Minimum Trading Value
225,050 JPY 1,444 USD
Market Cap
0.26T JPY 1.68B USD
Number of Trades
1,911
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
High
1-Year Average
1,736
1-Year High Feb 14, 2025
5,946
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 137,500 132,400 0.96
Nov 28, 2025 82,900 43,500 0.52
Nov 21, 2025 83,200 61,400 0.74
Nov 14, 2025 87,900 79,200 0.90
Nov 7, 2025 65,000 72,800 1.12
Company Profile
SAWAI GROUP HOLDINGS Co., Ltd. is a leading generic pharmaceutical company, specializing in lifestyle disease treatments and anti-cancer drugs. The company is focusing on expanding its business in the United States.
Sector
Pharmaceuticals
SAWAI GROUP HOLDINGS Co., Ltd. primarily engages in the manufacturing and sales of prescription and over-the-counter pharmaceuticals. The group consists of a holding company and eight consolidated subsidiaries, operating under a single segment of "manufacturing and sales of pharmaceuticals and related products." The core company, Sawai Pharmaceutical Co., Ltd., manufactures and sells pharmaceuticals to domestic distributors, wholesalers, other pharmaceutical manufacturers, and medical institutions. Medisa Shinyaku Co., Ltd. handles the sales of prescription drugs, while Kaken Shoyaku Co., Ltd. is responsible for the manufacturing and sales of prescription drugs and the supply of primary raw materials. Trust Pharmatech Co., Ltd. manufactures and sells prescription drugs and is entrusted with part of the research and development and manufacturing operations from Sawai Pharmaceutical. The group as a whole strives for efficient business operations and aims to strengthen its competitiveness in the pharmaceutical market.